These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19639292)

  • 21. Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.
    Díaz-Cabiale Z; Vivó M; Del Arco A; O'Connor WT; Harte MK; Müller CE; Martínez E; Popoli P; Fuxe K; Ferré S
    Neurosci Lett; 2002 May; 324(2):154-8. PubMed ID: 11988350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia.
    Kase H
    Biosci Biotechnol Biochem; 2001 Jul; 65(7):1447-57. PubMed ID: 11515525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functions of neuronal adenosine receptors.
    Haas HL; Selbach O
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):375-81. PubMed ID: 11111831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How does adenosine control neuronal dysfunction and neurodegeneration?
    Cunha RA
    J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.
    Lee HT; Emala CW
    Am J Kidney Dis; 2001 Sep; 38(3):610-8. PubMed ID: 11532695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects.
    Tebano MT; Martire A; Rebola N; Pepponi R; Domenici MR; Grò MC; Schwarzschild MA; Chen JF; Cunha RA; Popoli P
    J Neurochem; 2005 Nov; 95(4):1188-200. PubMed ID: 16271052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine and ATP receptors in the brain.
    Burnstock G; Fredholm BB; Verkhratsky A
    Curr Top Med Chem; 2011; 11(8):973-1011. PubMed ID: 21401499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicinal chemistry of adenosine A3 receptor ligands.
    Müller CE
    Curr Top Med Chem; 2003; 3(4):445-62. PubMed ID: 12570761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine receptor ligands-recent developments part I. Agonists.
    Muller CE
    Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of adenosine receptor ligands in medical imaging by positron emission tomography.
    Holschbach MH; Olsson RA
    Curr Pharm Des; 2002; 8(26):2345-52. PubMed ID: 12369949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
    Kreckler LM; Wan TC; Ge ZD; Auchampach JA
    J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats.
    Lopes LV; Cunha RA; Ribeiro JA
    J Neurophysiol; 1999 Dec; 82(6):3196-203. PubMed ID: 10601453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts.
    Ongaro A; Varani K; Masieri FF; Pellati A; Massari L; Cadossi R; Vincenzi F; Borea PA; Fini M; Caruso A; De Mattei M
    J Cell Physiol; 2012 Jun; 227(6):2461-9. PubMed ID: 21830213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors.
    Diógenes MJ; Assaife-Lopes N; Pinto-Duarte A; Ribeiro JA; Sebastião AM
    Hippocampus; 2007; 17(7):577-85. PubMed ID: 17421024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts.
    Sebastião AM; Assaife-Lopes N; Diógenes MJ; Vaz SH; Ribeiro JA
    Biochim Biophys Acta; 2011 May; 1808(5):1340-9. PubMed ID: 20603099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET Imaging of Adenosine Receptors in Diseases.
    Li J; Hong X; Li G; Conti PS; Zhang X; Chen K
    Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of adenosine receptors in human kidney proximal tubule (HK-2) cells.
    Lee HT; Emala CW
    Exp Nephrol; 2002; 10(5-6):383-92. PubMed ID: 12381923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medicinal chemistry of adenosine, P2Y and P2X receptors.
    Jacobson KA; Müller CE
    Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purinergic signalling: from normal behaviour to pathological brain function.
    Burnstock G; Krügel U; Abbracchio MP; Illes P
    Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosine and related drugs in brain diseases: present and future in clinical trials.
    Lopes LV; Sebastião AM; Ribeiro JA
    Curr Top Med Chem; 2011; 11(8):1087-101. PubMed ID: 21401493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.